Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The Cancer-Specific Health Economic Measure QLU-C10D is Valid and Responsive for Assessing Health Utility in Patients with Thyroid Cancer.
Pilz MJ, Seyringer S, Singer S, Ioannidis G, Sykiotis GP, Arraras JI, Husson O, Iakovou I, Fanetti G, Führer D, Inhestern J, Kiyota N, Locati LD, Pinto M, Gama RR, King MT, Norman R, Gamper EM; EORTC Quality of Life Group. Pilz MJ, et al. Among authors: seyringer s. Thyroid. 2024 Nov;34(11):1356-1370. doi: 10.1089/thy.2024.0396. Epub 2024 Oct 30. Thyroid. 2024. PMID: 39475110
Cancer-Specific Health Utilities: Evaluation of Core Measurement Properties of the EORTC QLU-C10D in Lung Cancer Patients-Data from Four Multicentre LUX-Lung Trials, Applying Six Country Tariffs.
Pilz MJ, Seyringer S, Al-Naesan I, King MT, Bottomley A, Norman R, Schlosser L, Hell T, Gamper EM; EORTC Quality of Life Group. Pilz MJ, et al. Among authors: seyringer s. Pharmacoecon Open. 2024 Jul;8(4):627-640. doi: 10.1007/s41669-024-00484-9. Epub 2024 May 2. Pharmacoecon Open. 2024. PMID: 38696019 Free PMC article.
The EORTC QLU-C10D is a valid cancer-specific preference-based measure for cost-utility and health technology assessment in the Netherlands.
Pilz MJ, Seyringer S, Hallsson LR, Bottomley A, Jansen F, King MT, Norman R, Rutten MJ, Verdonck-de Leeuw IM, Siersema PD, Gamper EM. Pilz MJ, et al. Among authors: seyringer s. Eur J Health Econ. 2024 Dec;25(9):1539-1555. doi: 10.1007/s10198-024-01670-6. Epub 2024 Mar 14. Eur J Health Econ. 2024. PMID: 38483665 Free PMC article.
Bottom Up Ethics - Neuroenhancement in Education and Employment.
Bard I, Gaskell G, Allansdottir A, da Cunha RV, Eduard P, Hampel J, Hildt E, Hofmaier C, Kronberger N, Laursen S, Meijknecht A, Nordal S, Quintanilha A, Revuelta G, Saladié N, Sándor J, Santos JB, Seyringer S, Singh I, Somsen H, Toonders W, Torgersen H, Torre V, Varju M, Zwart H. Bard I, et al. Among authors: seyringer s. Neuroethics. 2018;11(3):309-322. doi: 10.1007/s12152-018-9366-7. Epub 2018 May 1. Neuroethics. 2018. PMID: 30220937 Free PMC article.
Public views on gene editing and its uses.
Gaskell G, Bard I, Allansdottir A, da Cunha RV, Eduard P, Hampel J, Hildt E, Hofmaier C, Kronberger N, Laursen S, Meijknecht A, Nordal S, Quintanilha A, Revuelta G, Saladié N, Sándor J, Santos JB, Seyringer S, Singh I, Somsen H, Toonders W, Torgersen H, Torre V, Varju M, Zwart H. Gaskell G, et al. Among authors: seyringer s. Nat Biotechnol. 2017 Nov 9;35(11):1021-1023. doi: 10.1038/nbt.3958. Nat Biotechnol. 2017. PMID: 29121022 No abstract available.